CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 340 participants.
Also called NCT05726526
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 340 participants
- Sponsor
- University of Manitoba
- Registry
-
NCT05726526
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05726526. Randomized; single masking; primary purpose supportive care. Start 2022-06-30 (actual); primary completion 2027-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
- Acronym
- VIEWER
- Condition
- Chronic Kidney Disease Stage 5
- Condition
- End Stage Renal Disease
- Intervention (Device)
- VIEWER virtual care platform
- Lead sponsor
- University of Manitoba
Record details
- Record id
cardio:ct-nct05726526- Content hash
cc1087ae99f30b2f401e38c51088af635db1f8ccd985ab0c7322b54cd4a5b8ac